IRIS
MAZZARINO, Maria Clorinda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.633
AS - Asia 1.359
EU - Europa 1.304
SA - Sud America 263
AF - Africa 200
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 7.770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.481
SG - Singapore 652
CN - Cina 557
UA - Ucraina 411
IE - Irlanda 366
BR - Brasile 235
IT - Italia 178
CA - Canada 138
CI - Costa d'Avorio 132
RU - Federazione Russa 108
DE - Germania 73
SE - Svezia 53
SN - Senegal 44
IN - India 32
GB - Regno Unito 31
VN - Vietnam 19
CH - Svizzera 14
FR - Francia 14
IR - Iran 14
PL - Polonia 14
IQ - Iraq 12
KR - Corea 11
MX - Messico 11
UZ - Uzbekistan 10
AR - Argentina 9
BD - Bangladesh 9
CO - Colombia 9
HK - Hong Kong 9
NL - Olanda 9
TR - Turchia 9
ZA - Sudafrica 9
AT - Austria 8
EU - Europa 7
GR - Grecia 6
JP - Giappone 5
MA - Marocco 5
BE - Belgio 4
BG - Bulgaria 4
EC - Ecuador 4
FI - Finlandia 4
AE - Emirati Arabi Uniti 3
KE - Kenya 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
BY - Bielorussia 2
ES - Italia 2
LB - Libano 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BW - Botswana 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 7.770
Salva come PNG Salva come JPEG
Città #
Santa Clara 666
Dallas 587
Jacksonville 494
Singapore 417
Chandler 405
Dublin 367
Houston 312
Chicago 220
Boardman 180
Abidjan 132
Nanjing 117
Toronto 109
Cambridge 108
Lawrence 107
Andover 106
Beijing 88
Ashburn 85
Des Moines 78
San Mateo 67
Catania 65
Grafing 47
Wilmington 46
Dakar 44
Hefei 44
Hebei 35
Nanchang 35
Los Angeles 34
Saint Petersburg 30
The Dalles 27
Columbus 25
Jiaxing 25
Council Bluffs 22
Shenyang 22
Civitanova Marche 19
San Francisco 19
São Paulo 18
Tianjin 17
Changsha 16
Florence 15
Ottawa 15
Ardabil 13
Leawood 13
New York 12
Bremen 11
Rio de Janeiro 11
Augusta 10
Brooklyn 10
Kunming 10
Norwalk 10
Seoul 10
Monmouth Junction 9
Chennai 8
Hangzhou 8
Ningbo 8
Seattle 8
Warsaw 8
Boston 7
Ho Chi Minh City 7
Hong Kong 7
Jinan 7
London 7
Moscow 7
Baghdad 6
Falls Church 6
Mumbai 6
Misterbianco 5
Porto Alegre 5
Tashkent 5
Tokyo 5
Amsterdam 4
Atlanta 4
Belo Horizonte 4
Brussels 4
Caxias do Sul 4
Curitiba 4
Dearborn 4
Den Haag 4
Goiânia 4
Guangzhou 4
Hanoi 4
Johannesburg 4
Kiev 4
Viagrande 4
Washington 4
Ankara 3
Ann Arbor 3
Bangalore 3
Changchun 3
Denver 3
Duhok 3
Lausanne 3
Liberty Lake 3
Mexico City 3
Montreal 3
Mountain View 3
Munich 3
Nairobi 3
Salvador 3
Shanghai 3
Stockholm 3
Totale 5.612
Salva come PNG Salva come JPEG
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 347
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance. 303
Advances in targeting signal transduction pathways. 148
Absence of BRAF gene mutation in non-melanoma skin tumors 128
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients 125
Analysis of hepatitis C virus infection among health-care workers: an observational study 115
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene 107
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 106
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 103
Analysis of BRAF mutation in primary and metastatic melanoma 101
Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients 100
Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus 98
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 98
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 97
Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes 96
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 95
Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract 91
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 91
B-cell neoplasia in the context of HCV infection: A distinct entity? 89
Proinflammatory circulating molecules in peripheral arterial disease 86
Analysis of matrix metalloproteinase-9 gene polymorphism-1562 C/T in patients suffering from systemic sclerosis with and without ulcers 86
Vitamin D3: an ever green molecule 85
Analysis of MMP-9 gene polymorphism 1562C/T in patients suffering from systemic sclerosis with and without ulcers 85
Defective function of the fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset 83
Detection of BRAF gene mutation in primary choroidal melanoma tissue 82
Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study 79
Analysis of osteopontin and matrix metalloproteinase-9 in prostate cancer 79
Behavior of complement and anti-complement factors in the course of hepatic regeneration and degeneration 78
Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression 76
CD155/Neel-5 immunolocallization in melanocytic skin lesions 76
Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients 76
IL-2 RECEPTORS, NK AND LAK CYTOTOXICITY OF LYMPHOCYTES IN BREAST-CARCINOMA DURING PROLONGED THYMOPENTIN THERAPY 75
S100A7: A rAMPing up AMP molecule in psoriasis 74
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 74
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 74
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 74
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 73
Role of BRAF mutations in hematopoietic malignancies and the induction of cytokine-independence-synergy with PI3K/Akt pathway 72
IL2 and its receptors in elderly subjects on hemodialysis 72
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 72
Role of Hypoxia and Autophagy in MDA-MB-231 Invasiveness 71
Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C 70
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 70
Jagged-1 expression is downregulated in skin from biologic-treated psoriatic patients 70
Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract 69
Regulation of drug and immune resistance by YY1 in cancer 68
S100A7, Jab1, and p27 kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line 68
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease 67
Biologically induced improvement of PASI score is associated with a decline of S100A7 expression in psoriatic skin lesions. A preliminary immunohistochemical study 67
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance 67
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 66
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 66
IL-18 nelle infezioni virali ricorrenti in età pediatrica 66
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 66
Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte 66
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis 65
Rituximab for treatment of lymphoproliferative disorders associated with hepatitis C virus (HCV) infection 65
CD155/Necl-5 immunolocalization in melanocytic skin lesions 65
Biological therapy induces expression changes in Notch pathway in psoriasis 65
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 65
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 65
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 65
Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis 64
High circulating levels of cytockines (IL6 and TNFα), adhesion molecules (VICAM-1 and ICAM-1) and selectines in patients with peripheral arterial disease at rest and after a treadmill-test 64
CIRCULATING IMMUNOCOMPLEXES AND LARYNGEAL CARCINOMA 64
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients 64
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 63
Immunohistocemical localization of NECL-5 in melanocytic skin lesions. Preliminary observations 62
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 62
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review) 60
Insight into the role of microRNAs in brain tumors (review) 59
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection 57
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 57
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 57
Novel NO-donating compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo 57
Modulation of Chitotriosidase During Macrophage Differentiation 57
FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population 57
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 56
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation 56
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 56
Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip 56
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer 55
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes 55
Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin 55
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients 54
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 53
Jagged-1/Notch-1/Hes-1 pathway in psoriatic patients: effects of biological therapy 53
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 53
S100A7 in psoriasis: Immunodetection and activation by CRISPR technology 53
Osteopontin and matrix metalloptroteinase-9 as markers of early detection of prostate cancer development 52
Immunolocalization of FOXP3 in HCV-infected liver biopsies. Preliminary observations 52
Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study 52
Preoperative rIL-2 treatment in renal cancer: Early and late effects on lymphocyte subsets and proliferation, NK activity, IL-6 in vivo and in vitro production 50
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 50
Prognostic significance of YY1 in High Grade Lymphomas 49
Venous stasis causes release of interleukin 1β (IL - 1β), interleukin 6 (IL – 6) and tumor necrosis factor alpha (TNFα) by monocite macrophage 48
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection 45
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 45
Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: Role of L-propionyl carnitine administration 45
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients. 42
Totale 7.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021681 0 0 99 2 168 9 97 0 105 0 179 22
2021/2022793 102 107 0 8 126 6 113 24 75 0 15 217
2022/20231.167 117 53 20 105 124 212 2 202 269 12 40 11
2023/2024500 22 75 22 42 11 122 1 51 9 7 85 53
2024/20252.170 21 446 100 49 499 282 30 81 186 179 144 153
2025/20261.093 296 340 457 0 0 0 0 0 0 0 0 0
Totale 7.904